These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. New advances in the second-line treatment of small cell lung cancer. Hurwitz JL; McCoy F; Scullin P; Fennell DA Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917 [TBL] [Abstract][Full Text] [Related]
25. [Molecular targeted therapies in small-cell lung cancer]. Levy A; Malouf GG; Besse B; Massard C; Soria JC Bull Cancer; 2010 May; 97(5):535-45. PubMed ID: 20093224 [TBL] [Abstract][Full Text] [Related]
26. Treatment of limited disease small cell lung cancer. De Ruysscher D Eur J Cancer; 2009 Sep; 45 Suppl 1():425-6. PubMed ID: 19775657 [No Abstract] [Full Text] [Related]
27. Basket Trials: Just the End of the First Quarter. Stenzinger A; Weichert W; Lennerz JK; Klauschen F J Clin Oncol; 2015 Sep; 33(25):2823-4. PubMed ID: 26169614 [No Abstract] [Full Text] [Related]
29. Update on new drugs in small cell lung cancer. Horn L; Castellanos EL; Johnson DH Expert Opin Investig Drugs; 2011 Apr; 20(4):441-5. PubMed ID: 21395484 [TBL] [Abstract][Full Text] [Related]
30. Targeting an autocrine loop in small-cell lung cancer: irrelevant target or ineffective drug? Glisson BS Clin Lung Cancer; 2010 Jul; 11(4):222. PubMed ID: 20630822 [No Abstract] [Full Text] [Related]
31. Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature. Jallad B; Hamdi T; Latta S; Alhosaini MN; Kheir F; Iroegbu N Onkologie; 2011; 34(3):129-31. PubMed ID: 21358219 [No Abstract] [Full Text] [Related]
33. Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions. Allen J; Jahanzeb M Clin Lung Cancer; 2008 Sep; 9(5):262-70. PubMed ID: 18953759 [TBL] [Abstract][Full Text] [Related]
34. Reply to A. Stenzinger et al. Thomas A; Lopez-Chavez A; Giaccone G J Clin Oncol; 2015 Sep; 33(25):2824. PubMed ID: 26169619 [No Abstract] [Full Text] [Related]
35. Role of surgery for small cell lung cancer. Friedberg J; Lotano VE Curr Probl Cancer; 2012; 36(3):117-30. PubMed ID: 22495058 [No Abstract] [Full Text] [Related]
36. Doubling down with inhibitors of Notch and Hedgehog signaling pathways. Weiss GJ J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337 [No Abstract] [Full Text] [Related]
37. Medical treatment of small cell lung cancer: state of the art and new development. Sgambato A; Casaluce F; Maione P; Rossi A; Sacco PC; Panzone F; Ciardiello F; Gridelli C Expert Opin Pharmacother; 2013 Oct; 14(15):2019-31. PubMed ID: 23901936 [TBL] [Abstract][Full Text] [Related]
38. Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand? Agarwal V; Lind MJ; Cawkwell L Cancer Treat Rev; 2011 Nov; 37(7):533-42. PubMed ID: 21183281 [TBL] [Abstract][Full Text] [Related]